Synthesis reveals cytotoxicity of a combretastatin A4 analogue in cell lines, suggesting potential for heterocyclic derivatives.
A method for the synthesis of 3,4-diaryl-5-morpholinoisoxazoles was developed, featuring the optimization of reaction conditions to introduce a morpholine moiety at the 5-position of 5-chloroisoxazoles. The representative compound 9 was prepared and evaluated in vitro , demonstrating moderate water solubility along with cytotoxic activity against selected cell lines. This modification strategy provides a viable approach for further structural diversification of combretastatin A4 analogues within the isoxazole series, enabling the expansion of a library of heterocyclic derivatives with improved physicochemical properties.
No takes yet. Share an insight, caveat, or question.
Karetnikov et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: